⇘ BioNTech predicts positive growth in oncology by 2026, amidst a challenging COVID-19 vaccine market
BioNTech , a leading biotech company, announced that 90% of revenue for 2024 will accrue at end of the year. Further, it identified 2026 as...
about 1 year ago